Executives/Astellas Pharma CEO
Naoki Okamura, CEO of Astellas Pharma

Who is the CEO of Astellas Pharma in 2026?

Naoki Okamura is the Chief Executive Officer, Representative Director and President of Astellas Pharma. Naoki has held the CEO seat since April 2023.

Updated September 24, 2026
Time in seat
3 years
CEO since April 2023
Years at company
21 years
Joined Astellas Pharma April 2005
Education
The University of Tokyo
BSc, molecular biology
Summary
  • Naoki Okamura rose through Astellas Pharma: Senior Director, Licensing & Alliances from April 2005, then Chief Strategy Officer from April 2018, before taking the CEO seat in April 2023.
  • Naoki Okamura holds a BSc, molecular biology from The University of Tokyo.

Current company

Astellas Pharma

Astellas Pharma is a Japanese pharmaceutical company.

pharmaceutical industryHeadquartered in ChūōFounded 2005Listed on the Tokyo Stock Exchange

Source: Wikidata

Career and education

Naoki Okamura joined Astellas Pharma in April 2005 and has been CEO since April 2023.

Career

  1. Astellas Pharma2005 to present
    • President and CEOApril 2023 to present
    • Chief Strategy OfficerApril 2018 to March 2023
    • Vice President, Head of Corporate PlanningApril 2016 to March 2018
    • Vice President, Head of Business DevelopmentJuly 2014 to March 2016
    • Senior Director, Licensing & AlliancesOctober 2011 to March 2012
    • Senior Director, Licensing & AlliancesApril 2005 to September 2010

Sources: LinkedIn profile

Education

The University of Tokyo, BSc, molecular biologySource

Decision makers by function

240+ decision makers at Astellas Pharma in Unify, vice president level and above. Choose a function to see who leads it.

Decision maker preview

Top decision makers at Astellas Pharma

Vice president level and above, most senior first
Anjana HarveChief Digital Officer · USA@astellas.com
Kevin WhiteheadSenior Vice President, Head of Supply Chain Management · CHE@astellas.com
Victor TorresHead of Transformation Office, SVP · GBR@astellas.com
Sai VijayanathanSenior Vice President Enterprise and Corporate Financial Planning & Analysis · USA@astellas.com
See every decision maker at Astellas Pharma

Unlock every decision maker at Astellas Pharma

Get verified profiles, contact data, and live buying signals in Unify.

Leadership team at Astellas Pharma

Naoki Okamura leads a leadership team of 8 published executives. The most recent appointment is Katsuyoshi Sugita as Representative Director, Executive Vice President, Chief People Officer (CPO), in seat since April 2025.

Most senior 5 of 8

NameTitleIn seat since
Naoki OkamuraRepresentative Director, President and Chief Executive Officer (CEO)April 2023
Atsushi KitamuraChief Financial Officer (CFO)Not stated
Tatjana DragovicGeneral Counsel and Chief Ethics & Compliance Officer (GC & CECO)Not stated
Katsuyoshi SugitaRepresentative Director, Executive Vice President, Chief People Officer (CPO)April 2025
Tadaaki TaniguchiChief Research & Development Officer (CRDO)Not stated

Sources: Astellas leadership page

Frequently asked questions

Who is the CEO of Astellas Pharma?

Naoki Okamura is the Chief Executive Officer, Representative Director and President of Astellas Pharma. Naoki has held the CEO seat since April 2023.

When did Naoki Okamura become CEO of Astellas Pharma?

Naoki Okamura has been CEO of Astellas Pharma since April 2023, according to LinkedIn profile.

How long has Naoki Okamura been CEO of Astellas Pharma?

Naoki Okamura has been CEO of Astellas Pharma for 3 years, since April 2023.

Who else leads Astellas Pharma?

Atsushi Kitamura (Chief Financial Officer (CFO)), Tatjana Dragovic (General Counsel and Chief Ethics & Compliance Officer (GC & CECO)), Katsuyoshi Sugita (Representative Director, Executive Vice President, Chief People Officer (CPO)), Tadaaki Taniguchi (Chief Research & Development Officer (CRDO)), and 3 more. Source: Astellas leadership page.

Reach Astellas Pharma's decision makers

240+ leaders at vice president level and above, with verified work emails and phone numbers in Unify.

Methodology

The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.

Identity confirmed against Wikipedia, Astellas Pharma. Last verified: September 24, 2026.